Table 2.
Conventional cardiovascular magnetic resonance and echocardiography data of patients with giant cell myocarditis
| Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | |
|---|---|---|---|---|---|---|
| CMR parameters | ||||||
| LVEF (%) | 29 | 28 | 42 | 23 | 13 | 23 |
| RVEF (%) | 15 | 16 | 31 | 18 | 26 | 26 |
| LVMi (g/m2) | 48.4 | 50.5 | 70.5 | 46.1 | 50.8 | 41 |
| LVEDVi (mL/m2) | 53.5 | 110 | 87 | 78.7 | 124.3 | 97.5 |
| LVESVi (mL/m2) | 37.7 | 79 | 49.8 | 60 | 107.5 | 74.7 |
| RVEDVi (mL/m2) | 97.4 | 84.7 | 63.9 | 157.3 | 68.5 | 83.1 |
| RVESVi (mL/m2) | 82 | 70.9 | 43.8 | 129 | 50.3 | 61.1 |
| T2 ratio | 2.6 | 2.3 | 3.6 | 3 | 1.8 | 1.9 |
| LGE extent (%) | 21.6 | 44.2 | 31.2 | 38.3 | 56 | 47 |
| Echocardiography | ||||||
| RWMA | POS | POS | POS | POS | POS | POS |
| RVSP (mmHg) | 26 | 39 | 37 | 24 | 44 | 56 |
| Mitral valve E/A | NA | NA | NA | >2 | NA | >2 |
| Valve abnormality | Moderate TR | Moderate MR and TR | Mild MR and TR | Severe MR | Moderate MR, mild TR | Moderate MR and TR |
| Pericardial involvement | Small PE | Small PE | NI | Small PE | NI | NI |
CMR, cardiovascular magnetic resonance; LGE, late gadolinium enhancement; LVEDVi, indexed left ventricular end‐diastolic volume; LVEF, left ventricular ejection fraction; LVESVi, indexed left ventricular end‐systolic volume; LVMi, indexed left ventricular mass; MR, mitral regurgitation; NA, not available; NI, not involved; PE, pericardial effusion; POS, positive: hypokinesia in one or more segments; RVEDVi, indexed right ventricular end‐diastolic volume; RVEF, right ventricular ejection fraction; RVESVi, indexed right ventricular end‐systolic volume; RVSP, right ventricular systolic pressure; RWMA, regional wall motion abnormality; TR, tricuspid regurgitation.